FDA Approves New Software for Plasma Collection

Date: August 8, 2011

Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, has received U.S. Food and Drug Administration 510(k) clearance to market a new software release for its Autopheresis-C system used worldwide at blood and plasma centers to collect plasma from donors. The software includes new features designed to improve plasma collection, including automated and streamlined collection processes that reduce the need for operator intervention and help to improve work flow and reduce procedure times, and new confirmatory prompts to make accurate programming for target plasma volumes even easier.